NCT00532155 2025-09-10
VITAL
Sanofi
Phase 3 Completed
Clinical Trials
3 trialsNCT01967095 2018-11-13
Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01797471 2017-12-21
Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer
University of Miami
Phase NA Terminated